These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 143508)

  • 41. Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
    Rüther E; Schilkrut R; Ackenheil M; Eben E; Hippius H
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):33-6. PubMed ID: 981320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M; van Kammen DP; Kelley ME; Yao J
    Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seven cases of Huntington's disease in childhood and levodopa induced improvement in the hypokinetic--rigid form.
    Jongen PJ; Renier WO; Gabreëls FJ
    Clin Neurol Neurosurg; 1980; 82(4):251-61. PubMed ID: 6165509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of peripheral decarboxylase inhibition on HVA and 5HIAA in cerebrospinal fluid of depressed patients.
    Gaillard JM; Constantinidis J; Tissot R
    Neuropsychobiology; 1975; 1(1):26-31. PubMed ID: 1223666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Biochemical studies in delirium tremens (author's transl)].
    Athen D; Beckmann H; Ackenheil M; Markianos E
    Arzneimittelforschung; 1978; 28(9):1527-8. PubMed ID: 582551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurochemical specificity of learning: dopamine and motor learning.
    McEntee WJ; Mair RG; Langlais PJ
    Yale J Biol Med; 1987; 60(2):187-93. PubMed ID: 2437709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 51. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 52. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
    Banki CM; Molnar G
    Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypokinetic-rigid extrapyramidal side effects of neuroleptics: the relationship of the silent period in EMG and HVA and 5-HIAA in CSF.
    Yazici O; Hizal A; Eroğlu L; Baslo A; Yazici J
    J Neurol Neurosurg Psychiatry; 1986 Apr; 49(4):448-50. PubMed ID: 2422327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonin, lithium, and Huntington's chorea.
    Manyam NV
    Lancet; 1973 Aug; 2(7824):331. PubMed ID: 4124823
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma dopamine-beta-hydrozylase in Huntington's chorea.
    Mattsson B; Wetterberg L; Ross SB
    Acta Psychiatr Scand Suppl; 1974; 255():237-44. PubMed ID: 4282555
    [No Abstract]   [Full Text] [Related]  

  • 56. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F; Agren H; Hällgren R
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical markers for Huntington's chorea.
    McLean DR; Nihei T
    Can J Neurol Sci; 1980 Nov; 7(4):281-3. PubMed ID: 6260324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lysosomal enzymes, amino acids and acid metabolites of amines in Huntington's chorea.
    Yates CM; Magill BE; Davidson D; Murray LG; Wilson H; Pullar IA
    Clin Chim Acta; 1973 Feb; 44(1):139-45. PubMed ID: 4267642
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Huntington's chorea and levodopa.
    Schenk G; Leijnse-Ybema HJ
    Lancet; 1974 Mar; 1(7853):364. PubMed ID: 4131222
    [No Abstract]   [Full Text] [Related]  

  • 60. Noradrenergic and neuroradiological abnormalities in tardive dyskinesia.
    Kaufmann CA; Jeste DV; Shelton RC; Linnoila M; Kafka MS; Wyatt RJ
    Biol Psychiatry; 1986 Jul; 21(8-9):799-812. PubMed ID: 3015270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.